Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 249-172-0 | CAS number: 28706-33-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 975
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- no
- Remarks:
- pre GLP
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Direct Orange 118
- IUPAC Name:
- Direct Orange 118
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- S. typhimurium, other: TA1535, TA1537, TA1538, TA100 and TA98
- Details on mammalian cell type (if applicable):
- - Storage: at 4 °C in deep soft nutrient agar.
- Preparation of inoculum: the day before the test, fresh cultures were prepared by inoculating 10 ml of nutrient broth with each strain, which were incubated overnight at 37 °C. - Checked for histidine requirementt: perfromed.
- Checked for biotin requirement: perfromed.
- Checked for rfa character: perfromed.
- Checked for uvrB character: perfromed.
- Checked for presence or absence of the pKM101 plasmid: perfromed.
- Checked for spontaneous reversion rate to histidine prototrophy: perfromed.
Mutagenesis tests were not taken into consideration, if any check was outside the limits of the expected range
- Metabolic activation:
- with
- Metabolic activation system:
- rat liver S9
- Test concentrations with justification for top dose:
- In view of the lack of antibacterial activity at the 1000 µg/plate level, test item was tested for mutagenic activity at the doses of 1000, 100 and 10 µg/plate.
- Vehicle / solvent:
- The substance was dissolved 10 mg/ml in sterile distilled water and dimethylsulfoxide (DMSO) 1:1 V/V and further diluted in the same solvent according to the need. DMSO, which does not interfere with the result of Ames' test, was choosen as a solvent because it gives obviously sterile solutions.
Controls
- Untreated negative controls:
- yes
- Remarks:
- spontaneous reversion rate
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- other: 2-aminofluorene and diazoacetylglycinamide
- Details on test system and experimental conditions:
- METHOD OF APPLICATION
0.1 ml of DMSO containing the required amount of dye, 0.1 ml of an overnight culture of each tester strain containing 10^7 bacteria and 0.5 ml of S9-mix were added in sequence to each top agar tube. The contents of each tube were quickly mixed and poured on the surface of a VB plate.
INCUBATION PERIOD: revertant colonies were counted after 2 days of incubation at 37 °C and compared with revertants obtained from controls prepared in the same way, dye omitted.
REPLICATE: tests were carried out in triplicate.
MEDIA
Vogel-Bonner E agar medium (VB) has the following composition: MgSO4 × 7H2O 0.2 g/l, citric acid × H2O 2 g/l, K2PO4 10 g/l, NaNH4HPO4 × 4 H2O, glucose 2 g/l, Agar 15 g/l.
It was prepared by mixing 750 ml of 2 % molten autoclave sterilized water agar with 250 ml of 4 times concentrated salt solution and 10 ml of 20 % glucose solution autoclaved separately. For the antibacterial test histidine was also added to give a final concentration.of 10 µg/ml.
10 cm plastic petri dishes were prepared containing 20 ml each of VB agar and used within 3 days from preparation.
Top agar was prepared by mixing 100 ml of autoclave sterilized 0.6 % agar and 0.5 % NaCl in water with 10 ml of a millipore filter sterilized 0.5 mM histidine, 0.5 mM biotin solution. Top agar was dispensed in 2 ml amounts into 16 × 100 mm glass tubes kept at 42 °C.
CYTOTOXICITY TEST
0.1 ml of DMSO containing 1000 µg of test item, 0.1 ml of a 10^-5 dilution of an overnight culture of TA1535 or TA98 containing between 100 and 500 colony forming units (CFU) and 0.5 ml of S9-mix were added in sequence to each top agar tube.
The contents of each tube were quickly mixed and poured on the surface of a histidine containing VB plate. Controls received exactly the same except that dye was omitted.
Colonies were counted after 24 hours of incubation at 37 °C. Tests were carried out in triplicate.
S9 mix
A liver supernatant fraction was prepared from Wistar male rats (170-250 g). Three rats each received a single i.p. injection of Aroclor 1254 (200 mg/ml in corn oil, 500 mg/kg). Five days after injection the rats were killed by cervical dislocation having been deprived of food for the last 16 h of life. The livers washed with 0.15 M KCl ice cold solution were weighed and transferred to a beaker containing 3 ml of KCl 0.15 M solution per gram of net weight of liver, minced with sterilesgssors and homogenized in a Potter-Evenh-jem apparatus with a teflon pestle. The homogenate was centrifuged for 10 min at 9000 g and the supernatant decanted and stored at -60 °C.
100 ml of S9-mix were prepared by mixing 10 ml of liver homogenate, 4 ml of nicotinamide adenine dinucleotide phosphate (NADP) 0.1 M, 0.5 ml of glucose-6-phosphate (G6P) 1 M, 2 ml of MgCl2 0.4 M, 2 ml of KCl 1.65 M, 50 ml of phosphate buffer pH 7.4 0.2 M, 31.5 ml of sterile distilled water NADP and G6P stock solutions were millipore filter sterilized and stored at -20 °C. The stock salt solutions were autoclave sterilized and stored at 4 °C.
Each batch of S9-mix was tested for sterility and activity.
Results and discussion
Test results
- Species / strain:
- S. typhimurium, other: TA1535, TA1537, TA1538, TA100 and TA98
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- It can be concluded that test item is without any mutagenic activity within the limits of the test system used.
For a better evaluation of the limits of validity of the above statement, it may be taken into consideration that 1 µg of 2-aminofluorene gave a relevant increase of revertants with strains TA1538 and TA98, while no revertants were caused by 1000 µg of test item.
Applicant's summary and conclusion
- Conclusions:
- It can be concluded that test item is without any mutagenic activity within the limits of the test system used.
- Executive summary:
The study was performed to investigate the potential of test item to induce gene mutations using the Salmonella typhimurium strains TA 1535, TA 1537, TA 1538, TA 98, and TA 100. The assay was performed with liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test article was tested at the following concentrations: 10, 100 and 1000 μg/plate.
No toxic effects occurred in the preliminary investigation. The test item resulted to be without any mutagenic activity within the limits of the test system used.
For a better evaluation of the limits of validity of the above statement, it may be taken into consideration that 1 µg of 2-aminofluorene gave a relevant increase of revertants with strains TA1538 and TA98, while no revertants were caused by 1000 µg of test item.
Conclusion
It can be concluded that test item is without any mutagenic activity within the limits of the test system used.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
